Skip to main content
Premium Trial:

Request an Annual Quote

President Trump Calls for 8 Percent Cut to NIH Budget

NEW YORK — President Donald Trump on Monday called for $38 billion in fiscal 2021 funding for the National Institutes of Health, representing an approximately 8 percent decrease from the its current $41.46 billion budget. 

The request comes as part of the White House's $4.89 trillion federal budget proposal for the upcoming fiscal year.

The budget plan includes cuts to every NIH institute including the National Cancer Institute, which would receive $5.69 billion down from $6.25 billion; the National Human Genome Research Institute, which would receive $550.1 million versus $606.3 million; and the National Institute of Allergy and Infectious Diseases, which would receive $5.45 billion compared with $5.89 billion in FY2020.

The request marks the fourth time President Trump has sought to cut spending to the NIH. Increasing the agency's funding has continued to garner wide bipartisan support in Congress, however, leading to annual increases during his presidency.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.